Inspire Medical Systems Approved to Begin Pivotal Clinical Trial

Inspire Medical Systems, a developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea, Tuesday said that the company has received approval from the U.S. Food and Drug Administration to begin its STAR pivotal clinical trial.
RTTNews